Rural adolescent attitudes toward smoking and weight loss: Relationship to smoking status

2008 ◽  
Vol 10 (2) ◽  
pp. 279-286 ◽  
Author(s):  
Melanie Bean ◽  
Karen Mitchell ◽  
Ilene Speizer ◽  
Diane Baer Wilson ◽  
Brian Smith ◽  
...  
Keyword(s):  
Weight Loss ◽  
Smoking Status ◽  
Adolescent Attitudes ◽  
Attitudes Toward Smoking ◽  
Rural Adolescent

scholarly journals Contribution of binge eating behaviour to cardiometabolic risk factors in subjects starting a weight loss or maintenance programme

2016 ◽  
Vol 116 (11) ◽  
pp. 1984-1992 ◽  
Author(s):  
Alessandro Leone ◽  
Giorgio Bedogni ◽  
Veronica Ponissi ◽  
Alberto Battezzati ◽  
Valentina Beggio ◽  
...  
Keyword(s):  
Physical Activity ◽  
Risk Factors ◽  
Weight Loss ◽  
Nutritional Status ◽  
Binge Eating ◽  
Regression Model ◽  
Cardiometabolic Risk ◽  
Smoking Status ◽  
Cardiometabolic Risk Factors ◽  
Binge Eaters

AbstractThe contribution of binge eating (BE) behaviour to cardiometabolic risk factors has been scarcely investigated so far. Previous studies have not considered the nutritional status and lifestyle of subjects suffering from BE. The aim of this study was to evaluate the contribution of BE to the metabolic syndrome (MS), its components, high total cholesterol and high LDL in a large sample of subjects, taking into account nutritional status, dietary habits, smoking status and physical activity. For this purpose, 5175 adults seeking a weight loss or maintenance programme were recruited. Anthropometrical measurements and blood parameters were measured. BE was evaluated using the Binge Eating Scale (BES). A fourteen-item questionnaire was used to evaluate the adherence to the Mediterranean diet. Smoking status and physical activity were investigated by interview. BE prevalence was 0·16 (95 % CI 0·15, 0·17). A sex- and age-adjusted Poisson regression model showed a higher prevalence of MS in binge eaters (0·33; 95 % CI 0·28, 0·37) compared with non-binge eaters (0·27; 95 % CI 0·25, 0·28, P=0·011). However, the statistical difference was lost after inclusion of BMI and lifestyle parameters in the multiple-adjusted model. We also evaluated the association between the continuous outcomes of interest and the BES score using a multivariable median regression model. We observed a positive, but clinically irrelevant, association between BES score and HDL levels (P<0·001). In conclusion, BE does not seem to be independently related to cardiometabolic risk factors. However, the screening and treatment of BE are of clinical relevance in order to reduce the risk of developing obesity.

Tobacco Use and Cessation Among a National Online Sample of Men Who Have Sex With Men in Malaysia

2020 ◽  
Vol 32 (8) ◽  
pp. 414-417
Author(s):  
Sin How Lim ◽  
Lujain Daghar ◽  
Christopher Bullen ◽  
Hanisah Muhammad Faiz ◽  
Mohd Akbar ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Sexual Minority ◽  
Online Survey ◽  
Smoking Status ◽  
Minority Group ◽  
Muslim Country ◽  
Psychosocial Needs ◽  
Current Smoking ◽  
Sex With Men ◽  
Attitudes Toward Smoking

Previous studies documented the health disparities in smoking among sexual minority populations, including men who have sex with men (MSM). However, smoking behaviors have never been examined among Malaysian MSM, a sexual minority group in a predominantly Muslim country. A total of 622 Malaysian MSM completed an anonymous online survey in 2017. Data on the demographics, smoking and substance use behaviors, psychosocial factors, and attitudes toward smoking cessation were collected and analyzed. The mean age was 28 years and 67% of participants were of Malay ethnicity. The prevalence of current smoking was 23% (n = 143), while former smokers were 9% (n = 59). Current smoking status was associated with HIV-positive status and risk behaviors, such as suicidality, alcohol use, and illicit drug use ( P = .001). Almost two thirds of current smokers had attempted to quit in the past year. Hence, comprehensive smoking cessation interventions addressing the psychosocial needs of MSM should be prioritized.

Smoking status and weight loss in three weight loss programs

2006 ◽  
Vol 7 (1) ◽  
pp. 61-68 ◽  
Author(s):  
Jennifer D. Lundgren ◽  
Patrick M. O'Neil ◽  
Corby K. Martin ◽  
Martin Binks
Keyword(s):  
Weight Loss ◽  
Smoking Status ◽  
Weight Loss Programs

scholarly journals Predictors of Longterm Changes in Body Mass Index in Rheumatoid Arthritis

2015 ◽  
Vol 42 (6) ◽  
pp. 920-927 ◽  
Author(s):  
Joshua F. Baker ◽  
Grant W. Cannon ◽  
Said Ibrahim ◽  
Candace Haroldsen ◽  
Liron Caplan ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Body Mass Index ◽  
Weight Loss ◽  
Body Mass ◽  
Inflammatory Markers ◽  
Smoking Status ◽  
Active Smoking ◽  
Factors Associated ◽  
Marginal Regression ◽  
Over Time

Objective.Low body mass index (BMI) is a risk factor for poor longterm outcomes in rheumatoid arthritis (RA). The purpose of this study was to identify factors associated with longterm changes in BMI.Methods.Subjects with RA from the Veterans Affairs (VA) Rheumatoid Arthritis (VARA) Registry (n = 1474) were studied. Information on inflammatory markers, presence of erosions, and smoking status were extracted from the VARA database. BMI was extracted from VA electronic medical records within 14 days of each visit date. VA pharmacy records were queried to identify prescriptions for specific RA therapies within 1 month of the visit date. We used robust generalized estimating equations marginal regression models to calculate independent associations between clinical variables and BMI over time. Similar models determined predictors of change in weight and risk of weight loss over the subsequent study observation period.Results.Increasing age, active smoking, and the presence of erosions at baseline were associated with lower BMI. Weight decreased over time among older adults. Factors associated with greater reductions in BMI over time and a greater risk of weight loss were higher inflammatory markers, smoking, older age, higher BMI, and less subsequent improvement in inflammation. Methotrexate use was associated with a lower risk of weight loss. The use of prednisone or anti-tumor necrosis factor therapies was not associated with change in BMI or the risk of weight loss independent of other factors.Conclusion.Greater age, greater inflammatory activity, and active smoking are associated with greater weight loss in RA over time.

scholarly journals Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database

2021 ◽  
Author(s):  
Christiane Lundegaard Haase ◽  
Sandra Lopes ◽  
Anne Helene Olsen ◽  
Altynai Satylganova ◽  
Volker Schnecke ◽  
...  
Keyword(s):  
Weight Loss ◽  
Smoking Status ◽  
High Body Mass Index ◽  
Baseline Period ◽  
Sleep Apnoea ◽  
Practice Research ◽  
Dietary Advice ◽  
Clinical Practice Research Datalink ◽  
Cvd Risk ◽  
The Impact

AbstractHigh body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and other outcomes is not well quantified. We examined the effect of weight loss on ten selected outcomes in a population from the UK Clinical Practice Research Datalink (CPRD) GOLD database. Included individuals were >18 years old at the index date (first BMI value between January 2001 and December 2010). They were categorised by their weight pattern between year 1 post-index and year 4 post-index (baseline period) as having stable weight (−5% to +5%) or weight loss (−25% to −10%, plus evidence of intervention or dietary advice to confirm intention to lose weight). For inclusion, individuals also required a BMI of 25.0–50.0 kg/m2 at the start of the follow-up period, during which the occurrence of ten obesity-related outcomes was recorded. Cox proportional hazard models adjusted for BMI, comorbidities, age, sex and smoking status were used to estimate relative risks for weight loss compared with stable weight. Individuals in the weight-loss cohort had median 13% weight loss. Assuming a BMI of 40 kg/m2 before weight loss, this resulted in risk reductions for T2D (41%), sleep apnoea (40%), hypertension (22%), dyslipidaemia (19%) and asthma (18%). Furthermore, weight loss was associated with additional benefits, with lower risk of T2D, chronic kidney disease, hypertension and dyslipidaemia compared with maintaining the corresponding stable lower BMI throughout the study. This study provides objective, real-world quantification of the effects of weight loss on selected outcomes, with the greatest benefits observed for the established CVD risk factors T2D, hypertension and dyslipidaemia.

scholarly journals Low BMI and weight loss aggravate COPD mortality in men, findings from a large prospective cohort: the JACC study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Hiroo Wada ◽  
Ai Ikeda ◽  
Koutatsu Maruyama ◽  
Kazumasa Yamagishi ◽  
Peter J. Barnes ◽  
...  
Keyword(s):  
Weight Loss ◽  
Weight Change ◽  
Prospective Cohort ◽  
Smoking Status ◽  
Baseline Survey ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Low Bmi ◽  
Large Prospective Cohort ◽  
Copd Mortality

AbstractTo clarify how low BMI and weight loss were associated with risk of chronic obstructive pulmonary disease (COPD) mortality, in a large prospective cohort of the general population across Japan, the Japan Collaborative Cohort Study, conducted between 1988 and 2009. A total of 45,837 male residents were observed for a median period of 19.1 years. Self-administered questionnaires, collecting information on BMI, weight loss since the age of 20, lifestyles, history of diseases, as well as records of COPD mortality, were analysed at 2019. During follow-up, 268 participants died from COPD. The multivariate-adjusted hazard ratio (95% confidence interval) of COPD mortality associated with a 1-SD increment of body mass index (BMI) was 0.48 (0.41–0.57), while for weight change from age of 20 (+ 2.0 kg) it was 0.63 (0.59–0.68). These associations were persistently observed after stratifications with smoking status, excluding those having airway symptoms in the baseline survey, and excluding early COPD deaths within 5, 10 and 15 years. Our study suggests that BMI and weight change since the age of 20 could be markers for COPD prognosis, indicated by risk of COPD mortality.

CPCNP en estadio II: radioterapia y uso de quimioterapia en pacientes inoperables

2020 ◽  
pp. 61-62
Author(s):  
Miriam Möller ◽  
Wolfgang Schütte
Keyword(s):  
Weight Loss ◽  
Surgical Resection ◽  
Smoking Status ◽  
Primary Outcome Measure ◽  
Concurrent Chemotherapy ◽  
Stage Ii ◽  
Curative Intent ◽  
Curative Therapy ◽  
Ecog Ps ◽  
The Impact

<b><i>Objectives:</i></b> Curative intent therapy of stage II NSCLC may include surgical resection or definitive radiotherapy. Primary management with surgery or radiotherapy may be influenced by patient and disease characteristics. We sought to perform a comparison of patients receiving surgery or radical radiation therapy as their curative treatment, and explore the impact of known prognostic factors on outcome. <b><i>Materials and methods:</i></b> A retrospective review was completed of all patients with stage II NSCLC referred to the BC Cancer Agency from 2005 to 2012. Cases were filtered to identify those receiving curative intent therapy including surgery or radiotherapy. Information was collected on known prognostic and predictive factors. The primary outcome measure was overall survival. We compared survival among patients receiving curative intent radiotherapy versus surgical intervention. <b><i>Results:</i></b> A total of 535 patients were referred. Of these, 245 (46%) received curative intent surgery, 132 (25%) curative intent radiotherapy, and 158 (30%) did not receive curative therapy. There were significant differences between cohorts with respect to median age, histology, ECOG PS, smoking status, and weight loss. Median OS was significantly different between cohorts: 61.4 m surgery, 26.5 m curative RT, and 13.1 m non-curative therapy. In a case-matched analysis, median OS remained superior for surgery at 101.6 m vs 28.1 m for curative RT. In a multivariate analysis, ECOG PS, weight loss, and treatment cohort all influenced survival. Among patients receiving curative intent radiotherapy, the use of concurrent chemotherapy and RT dose ≥ 60 Gy were associated with improved outcomes. <b><i>Conclusions:</i></b> Among patients with stage II NSCLC, many are unable to undergo standard of care surgical resection. Radiotherapy provides an inferior yet still curative option in the management of inoperable patients. Further work is needed to optimize outcomes in this population.

Sign in / Sign up

Export Citation Format

Share Document